Amundi
CVAC

Amundi’s CureVac CVAC Stock Holding History

Amundi’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-183,856
Closed -$995K – 1854
2025
Q3 		$995K Buy
183,856
+47,060
+34% +$255K ﹤0.01% 1155
2025
Q2 		$739K Buy
136,796
+67,310
+97% +$267K ﹤0.01% 1262
2025
Q1 		$197K Buy
69,486
+1,177
+2% +$4.09K ﹤0.01% 1677
2024
Q4 		$289K Sell
68,309
-54,048
-44% -$156K ﹤0.01% 1669
2024
Q3 		$354K Buy
122,357
+24,978
+26% +$82.3K ﹤0.01% 1515
2024
Q2 		$304K Buy
97,379
+34,693
+55% +$113K ﹤0.01% 1473
2024
Q1 		$153K Sell
62,686
-6,573
-9% -$23.1K ﹤0.01% 1685
2023
Q4 		$276K Buy
69,259
+15,293
+28% +$83K ﹤0.01% 1557
2023
Q3 		$320K Sell
53,966
-502
-0.9% -$4.43K ﹤0.01% 1493
2023
Q2 		$587K Buy
54,468
+7,369
+16% +$65.9K ﹤0.01% 1358
2023
Q1 		$323K Buy
47,099
+5,305
+13% +$46.2K ﹤0.01% 1450
2022
Q4 		$522K Buy
41,794
+1,848
+5% +$13.7K ﹤0.01% 1394
2022
Q3 		$329K Buy
39,946
+33,076
+481% +$386K ﹤0.01% 1400
2022
Q2 		$87K Buy
+6,870
New +$114K ﹤0.01% 1469

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Amundi's CVAC Position: Q4 2025 in Review

Amundi sold out of CureVac (CVAC) in Q4 2025, closing a stake of 183,856 shares — an estimated $995K sold.

Amundi first reported a position in CVAC in Q2 2022 and held it in 14 quarters. The position peaked at $995K in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Amundi reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Amundi sold 183,856 CureVac shares in Q4 2025, an estimated $995K.
  • Amundi first reported a position in CureVac in Q2 2022 and held it in 14 quarters.
  • Amundi's CureVac position peaked at $995K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Amundi's 13F filing for Q4 2025, filed 17 Feb 2026.